Literature DB >> 18034668

Analysis of drug transporter expression in human intestinal Caco-2 cells by real-time PCR.

Nathalie Maubon1, Marc Le Vee, Lina Fossati, Mathilde Audry, Eric Le Ferrec, Sebastien Bolze, Olivier Fardel.   

Abstract

Expression of drug transporters corresponds to a crucial parameter in intestinal Caco-2 cells widely used for investigating drug absorption. In order to characterize it in an accurate, reproducible and comparative manner, we analyzed mRNA levels of 19 influx and efflux drug transporters through real-time quantitative polymerase chain reaction assays combined with the use of a total RNA reference standard. Profiles of transporter expression were found to be significantly correlated in two independent Caco-2 cell clones and in human small intestine, which may support the use of Caco-2 cells for investigating intestinal drug transport. Several transporters were nevertheless quantitatively expressed at higher (MRP2, MRP3, MRP4, MRP5, MRP6, OATP-A, OATP-B, OCT1 and MCT1) or lower (BCRP) levels in Caco-2 cells comparatively to small intestine. Moreover, MDR1, MRP2, OATP-A and PEPT1 mRNA relative expression were found to differ in the two analyzed Caco-2 cell clones by at least a twofold factor, highlighting that some variations in transporter expression may occur in Caco-2 cells depending on cell origin, and therefore underlining the interest of carefully characterizing transporter levels in any Caco-2 cell clone before its use for drug transport assays.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18034668     DOI: 10.1111/j.1472-8206.2007.00550.x

Source DB:  PubMed          Journal:  Fundam Clin Pharmacol        ISSN: 0767-3981            Impact factor:   2.748


  24 in total

1.  Cyclooxygenase-deficient pancreatic cancer cells use exogenous sources of prostaglandins.

Authors:  Noriyuki Omura; Margaret Griffith; Audrey Vincent; Ang Li; Seung-Mo Hong; Kimberly Walter; Michael Borges; Michael Goggins
Journal:  Mol Cancer Res       Date:  2010-06-08       Impact factor: 5.852

2.  Breast cancer resistance protein (ABCG2) determines distribution of genistein phase II metabolites: reevaluation of the roles of ABCG2 in the disposition of genistein.

Authors:  Zhen Yang; Wei Zhu; Song Gao; Taijun Yin; Wen Jiang; Ming Hu
Journal:  Drug Metab Dispos       Date:  2012-06-26       Impact factor: 3.922

3.  Kefir improves bone mass and microarchitecture in an ovariectomized rat model of postmenopausal osteoporosis.

Authors:  H-L Chen; Y-T Tung; C-H Chuang; M-Y Tu; T-C Tsai; S-Y Chang; C-M Chen
Journal:  Osteoporos Int       Date:  2014-10-03       Impact factor: 4.507

4.  A Physiologically Based Pharmacokinetic Model for Ganciclovir and Its Prodrug Valganciclovir in Adults and Children.

Authors:  V Lukacova; P Goelzer; M Reddy; G Greig; B Reigner; N Parrott
Journal:  AAPS J       Date:  2016-07-22       Impact factor: 4.009

5.  Cellular Pharmacokinetic Model-Based Analysis of Genistein, Glyceollin, and MK-571 Effects on 5 (and 6)-Carboxy-2',7'-Dichloroflourescein Disposition in Caco-2 Cells.

Authors:  Callie Drennen; Erin Gorse; Robert E Stratford
Journal:  J Pharm Sci       Date:  2017-12-14       Impact factor: 3.534

6.  Absorption of montelukast is transporter mediated: a common variant of OATP2B1 is associated with reduced plasma concentrations and poor response.

Authors:  Edward B Mougey; Hua Feng; Mario Castro; Charles G Irvin; John J Lima
Journal:  Pharmacogenet Genomics       Date:  2009-02       Impact factor: 2.089

7.  Modulation of butyrate transport in Caco-2 cells.

Authors:  Pedro Gonçalves; João Ricardo Araújo; Maria João Pinho; Fátima Martel
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2008-11-21       Impact factor: 3.000

8.  Butyric acid increases transepithelial transport of ferulic acid through upregulation of the monocarboxylate transporters SLC16A1 (MCT1) and SLC16A3 (MCT4).

Authors:  Kerstin Ziegler; Asimina Kerimi; Laure Poquet; Gary Williamson
Journal:  Arch Biochem Biophys       Date:  2016-02-09       Impact factor: 4.013

9.  Colorectal neoplasia goes with the flow: prostaglandin transport and termination.

Authors:  Sanford D Markowitz
Journal:  Cancer Prev Res (Phila)       Date:  2008-03-19

10.  Factors affecting the sensitivity of human-derived esophageal carcinoma cell lines to 5-fluorouracil and cisplatin.

Authors:  Tetsuya Minegaki; Kohji Takara; Ryohei Hamaguchi; Masayuki Tsujimoto; Kohshi Nishiguchi
Journal:  Oncol Lett       Date:  2012-11-05       Impact factor: 2.967

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.